- Home
- GCMG vs IRMD Comparison
GCMG vs IRMD Comparison
Compare GCMG & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCMG
- IRMD
- Stock Information
- Founded
- GCMG 1971
- IRMD 1992
- Country
- GCMG United States
- IRMD United States
- Employees
- GCMG N/A
- IRMD N/A
- Industry
- GCMG Finance/Investors Services
- IRMD Medical/Dental Instruments
- Sector
- GCMG Finance
- IRMD Health Care
- Exchange
- GCMG Nasdaq
- IRMD Nasdaq
- Market Cap
- GCMG 554.1M
- IRMD 618.5M
- IPO Year
- GCMG N/A
- IRMD 2014
- Fundamental
- Price
- GCMG $11.75
- IRMD $54.65
- Analyst Decision
- GCMG Hold
- IRMD Strong Buy
- Analyst Count
- GCMG 5
- IRMD 1
- Target Price
- GCMG $13.20
- IRMD $60.00
- AVG Volume (30 Days)
- GCMG 301.5K
- IRMD 48.1K
- Earning Date
- GCMG 02-11-2025
- IRMD 02-06-2025
- Dividend Yield
- GCMG 3.75%
- IRMD 1.10%
- EPS Growth
- GCMG N/A
- IRMD 13.16
- EPS
- GCMG N/A
- IRMD 1.46
- Revenue
- GCMG $462,593,000.00
- IRMD $71,305,130.00
- Revenue This Year
- GCMG $16.00
- IRMD $13.29
- Revenue Next Year
- GCMG $12.44
- IRMD $10.76
- P/E Ratio
- GCMG $155.00
- IRMD $37.43
- Revenue Growth
- GCMG 8.20
- IRMD 13.23
- 52 Week Low
- GCMG $8.05
- IRMD $40.18
- 52 Week High
- GCMG $12.58
- IRMD $57.95
- Technical
- Relative Strength Index (RSI)
- GCMG 40.32
- IRMD 56.00
- Support Level
- GCMG $11.66
- IRMD $51.58
- Resistance Level
- GCMG $12.55
- IRMD $54.93
- Average True Range (ATR)
- GCMG 0.28
- IRMD 1.79
- MACD
- GCMG -0.10
- IRMD -0.14
- Stochastic Oscillator
- GCMG 10.11
- IRMD 62.40
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.